Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) versus VAC alternating with Vincristine, Topotecan and Cyclophosphamide for Patients with Intermediate-Risk Rhabdomyosarcoma

Author(s)

Journal

  • Protocol D9803

    Protocol D9803

Cited by:  1

Codes

  • NII Article ID (NAID)
    10017266576
  • Article Type
    Other
  • Data Source
    CJPref 
Page Top